Ciprofloxacin

Major

Ciprofloxacin Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Ciprofloxacin Amitriptyline Elavil Explained An increased risk of QT interval prolongation and torsade de pointes Details Ciprofloxacin Sertraline Explained An increased risk of QT interval prolongation Details Ciprofloxacin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation, increased buprenorphine exposure and an increased risk of buprenorphine-related adv... Details Ciprofloxacin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Ciprofloxacin Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Ciprofloxacin Simvastatin Flolipid Explained Increased simvastatin exposure and increased risk of myopathy or rhabdomyolysis Details Ciprofloxacin Acalabrutinib Calquence Increased acalabrutinib exposure and increased risk of toxicity Details Ciprofloxacin Acarbose Prandase® Explained Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Ciprofloxacin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Ciprofloxacin Arsenic Trioxide Trisenox An increased risk of QT interval prolongation and torsade de pointes Details Ciprofloxacin Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Ciprofloxacin Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation and torsade de pointes Details Ciprofloxacin Asenapine Transdermal Patch Secuado An increased asenapine exposure and an increased risk of QT interval prolongation Details Ciprofloxacin Avapritinib Ayvakit Increased avapritinib exposure and an increased risk of the incidence and severity of adverse reactions Details Ciprofloxacin Azathioprine Azasan An increased risk of hepatotoxicity Details Ciprofloxacin Azithromycin AzaSite An increased risk of QT interval prolongation Details Ciprofloxacin Atorvastatin Atorvaliq An increased risk of myopathy or rhabdomyolysis Details Ciprofloxacin Cariprazine Vraylar Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure and an increased risk of QT prolon... Details Ciprofloxacin Alfuzosin UroXatral An increased risk of QT interval prolongation Details Ciprofloxacin Alogliptin Nesina Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Ciprofloxacin Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Ciprofloxacin Anagrelide Agrylin Increased anagrelide exposure and increased risk of QT interval prolongation Details Ciprofloxacin Bedaquiline Sirturo Increased bedaquiline exposure and an increased risk of QT interval prolongation Details Ciprofloxacin Bendamustine Injection Belrapzo Increased bendamustine exposure and an increased risk of bendamustine-related adverse effects Details Ciprofloxacin Bosutinib Bosulif Increased bosutinib exposure Details Ciprofloxacin Brexpiprazole Rexulti Increased brexpiprazole exposure and an increased risk of QT interval prolongation and/or torsade de pointes Details Ciprofloxacin Brigatinib Alunbrig Increased brigatinib exposure Details Ciprofloxacin Budesonide Entocort An increased risk of tendon rupture Details Ciprofloxacin Budesonide Nasal Spray Rhinocort An increased risk of tendon rupture Details Ciprofloxacin Budesonide Oral Inhalation Pulmicort An increased risk of tendon rupture Details Ciprofloxacin Canagliflozin Invokana Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Ciprofloxacin Chloroquine Aralen® Increased ciprofloxacin urinary excretion and an increased risk of QT interval prolongation and torsade de pointes Details Ciprofloxacin Cyclosporine Injection Atopica Increased risk of renal dysfunction and an increased cycloSPORINE exposure Details Ciprofloxacin Cyclosporine Ophthalmic Cequa Increased risk of renal dysfunction and an increased cycloSPORINE exposure Details Ciprofloxacin Dapagliflozin Farxiga Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Ciprofloxacin Dasatinib Phyrago An increased risk of QT interval prolongation Details Ciprofloxacin Deflazacort Emflaza An increased risk of tendon rupture Details Ciprofloxacin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Ciprofloxacin Delafloxacin Baxdela An increased risk of fluoroquinolones-related adverse reactions and an increased risk of seizures Details